These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12693374)

  • 21. Non-parametric methods to predict HIV drug susceptibility phenotype from genotype.
    DiRienzo AG; DeGruttola V; Larder B; Hertogs K
    Stat Med; 2003 Sep; 22(17):2785-98. PubMed ID: 12939786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The K65R mutation: selection, frequency, and possible consequences.
    Moyle GJ
    AIDS Read; 2004 Nov; 14(11):595-7, 601-3. PubMed ID: 15570671
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiretroviral rounds. Resistance: how do you know if you don't know?
    Campbell TB; Katzenstein D
    AIDS Clin Care; 2005 Mar; 17(3):26-7. PubMed ID: 15828117
    [No Abstract]   [Full Text] [Related]  

  • 24. Resistance and replication capacity assays: clinical utility and interpretation.
    Haubrich RH
    Top HIV Med; 2004; 12(2):52-6. PubMed ID: 15184711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV susceptibility testing--time for standards.
    Hill AM; Telenti A
    Antivir Ther; 2004 Aug; 9(4):463-4. PubMed ID: 15456076
    [No Abstract]   [Full Text] [Related]  

  • 26. Deadly risk of drug-resistant HIV.
    Gulland A
    Nurs Times; 2000 Dec 7-13; 96(49):6. PubMed ID: 11965965
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.
    Recsky MA; Brumme ZL; Chan KJ; Wynhoven B; Yip B; Dong WW; Heath KV; Montaner JS; Levy AR; Hogg RS; Harrigan PR
    J Infect Dis; 2004 Jul; 190(2):285-92. PubMed ID: 15216463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fact sheet on structured treatment interruption.
    Res Initiat Treat Action; 2003; 9(2):20-1. PubMed ID: 14989203
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug resistance guide being pondered by CDC. As HIV drug resistance rises, surveillance needed.
    AIDS Alert; 2003 Nov; 18(11):146-7. PubMed ID: 14674368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug resistance in antiretroviral therapy of HIV infection].
    Oette M; Häussinger D
    Med Klin (Munich); 2003 Dec; 98(12):692-9. PubMed ID: 14685670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV resistance testing. A clinical tool.
    Paul SM; Jorden VS
    N J Med; 2003 Sep; 100(9 Suppl):44-9; quiz 75-6. PubMed ID: 14556603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resisting resistance. A long road of unintentional missteps pays off.
    Sharp M
    Posit Aware; 2007; 18(2):24-5. PubMed ID: 17390486
    [No Abstract]   [Full Text] [Related]  

  • 33. A single case of multidrug-resistant HIV and rapid disease progression.
    O'Rourke M
    AIDS Clin Care; 2005 Mar; 17(3):21-2. PubMed ID: 15828115
    [No Abstract]   [Full Text] [Related]  

  • 34. Viro diversity (or, keeping up with HIV's evolutionary caprice).
    Mascolini M
    IAPAC Mon; 2001 Jul; 7(7):198-207. PubMed ID: 11785465
    [No Abstract]   [Full Text] [Related]  

  • 35. Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failure.
    Lohse N; Jørgensen LB; Kronborg G; Møller A; Kvinesdal B; Sørensen HT; Obel N; Gerstoft J;
    Antivir Ther; 2007; 12(6):909-17. PubMed ID: 17926645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.
    de Mendoza C; Martín-Carbonero L; Gallego O; Corral A; González-Lahoz J; Soriano V
    J Med Virol; 2005 May; 76(1):1-6. PubMed ID: 15778973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV therapy after treatment interruption in patients with multiple failure and more than 200 CD4+ T lymphocyte count.
    Jaafar A; Massip P; Sandres-Sauné K; Souyris C; Pasquier C; Aquilina C; Izopet J
    J Med Virol; 2004 Sep; 74(1):8-15. PubMed ID: 15258962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of primary antiretroviral resistance in Chilean patients recently infected with human immunodeficiency virus (HIV)].
    Acevedo W; Gallardo AM; Galaz J; Afani A; Cortés E
    Rev Med Chil; 2007 Nov; 135(11):1406-13. PubMed ID: 18259651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV drug resistance--a chink in the armor.
    Hirsch MS
    N Engl J Med; 2002 Aug; 347(6):438-9. PubMed ID: 12167687
    [No Abstract]   [Full Text] [Related]  

  • 40. Retrospective analysis of antiretroviral HIV treatment success based on medical history or guided by the reverse hybridisation LiPA HIV genotyping system.
    Alvarez M; García F; Martínez NM; Hernández Quero J; Louwagie J; De Brauwer A; Maroto MC
    J Med Virol; 2004 Jun; 73(2):151-7. PubMed ID: 15122786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.